Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Income towards Parent Company came in at -$1.4 billion in Q1 2026, down 1563.95% year-on-year from $97.7 million in Q1 2025, and down 1289.32% quarter-over-quarter from -$103.0 million in Q4 2025.
Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Income towards Parent Company across 18 years of filings, most recently posting -$1.4 billion for Q1 2026.
- Income towards Parent Company for Q1 2026 came in at -$1.4 billion, down 1563.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 1412.35% YoY), and the FY2025 annual result was $120.0 million, up 266.67% from the prior year.
- Income towards Parent Company came in at -$1.4 billion for Q1 2026 at Bausch Health Companies, down from -$103.0 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
- The 5-year median for Income towards Parent Company is -$77.0 million (2024), against an average of -$129.8 million.
- Across the five-year window, Income towards Parent Company soared 12900.0% in 2025 and slumped 1563.95% in 2026, its largest moves.
- Bausch Health Companies' Income towards Parent Company stood at -$410.0 million in 2022, then soared by 88.54% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then sank by 205.1% to -$103.0 million in 2025, then tumbled by 1289.32% to -$1.4 billion in 2026.
- The last three Income towards Parent Company figures came in at -$1.4 billion (Q1 2026), -$103.0 million (Q4 2025), and $181.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.92 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.43 Bn |
| Dec 31, 2025 | -103.00 Mn |
| Sep 30, 2025 | 181.00 Mn |
| Jun 30, 2025 | 128.00 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | 98.00 Mn |
| Sep 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | -77.00 Mn |
| Dec 31, 2023 | -47.00 Mn |
| Sep 30, 2023 | -382.00 Mn |
| Jun 30, 2023 | 27.00 Mn |
| Mar 31, 2023 | -209.00 Mn |
| Dec 31, 2022 | -410.00 Mn |
| Sep 30, 2022 | 403.00 Mn |
| Jun 30, 2022 | -139.00 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 72.00 Mn |
| Sep 30, 2021 | 191.00 Mn |
| Jun 30, 2021 | -669.00 Mn |